Sebaceous carcinoma: evidence-based clinical practice guidelines. Issue 12 (December 2019)
- Record Type:
- Journal Article
- Title:
- Sebaceous carcinoma: evidence-based clinical practice guidelines. Issue 12 (December 2019)
- Main Title:
- Sebaceous carcinoma: evidence-based clinical practice guidelines
- Authors:
- Owen, Joshua L
Kibbi, Nour
Worley, Brandon
Kelm, Ryan C
Wang, Jordan V
Barker, Christopher A
Behshad, Ramona
Bichakjian, Christopher K
Bolotin, Diana
Bordeaux, Jeremy S
Bradshaw, Scott H
Cartee, Todd V
Chandra, Sunandana
Cho, Nancy L
Choi, Jennifer N
Council, M Laurin
Demirci, Hakan
Eisen, Daniel B
Esmaeli, Bita
Golda, Nicholas
Huang, Conway C
Ibrahim, Sherrif F
Jiang, S Brian
Kim, John
Kuzel, Timothy M
Lai, Stephen Y
Lawrence, Naomi
Lee, Erica H
Leitenberger, Justin J
Maher, Ian A
Mann, Margaret W
Minkis, Kira
Mittal, Bharat B
Nehal, Kishwer S
Neuhaus, Isaac M
Ozog, David M
Petersen, Brian
Rotemberg, Veronica
Samant, Sandeep
Samie, Faramarz H
Servaes, Sabah
Shields, Carol L
Shin, Thuzar M
Sobanko, Joseph F
Somani, Ally-Khan
Stebbins, William G
Thomas, J Regan
Thomas, Valencia D
Tse, David T
Waldman, Abigail H
Wong, Michael K
Xu, Y Gloria
Yu, Siegrid S
Zeitouni, Nathalie C
Ramsay, Timothy
Reynolds, Kelly A
Poon, Emily
Alam, Murad
… (more) - Abstract:
- Summary: Sebaceous carcinoma usually occurs in adults older than 60 years, on the eyelid, head and neck, and trunk. In this Review, we present clinical care recommendations for sebaceous carcinoma, which were developed as a result of an expert panel evaluation of the findings of a systematic review. Key conclusions were drawn and recommendations made for diagnosis, first-line treatment, radiotherapy, and post-treatment care. For diagnosis, we concluded that deep biopsy is often required; furthermore, differential diagnoses that mimic the condition can be excluded with special histological stains. For treatment, the recommended first-line therapy is surgical removal, followed by margin assessment of the peripheral and deep tissue edges; conjunctival mapping biopsies can facilitate surgical planning. Radiotherapy can be considered for cases with nerve or lymph node involvement, and as the primary treatment in patients who are ineligible for surgery. Post-treatment clinical examination should occur every 6 months for at least 3 years. No specific systemic therapies for advanced disease can be recommended, but targeted therapies and immunotherapies are being developed.
- Is Part Of:
- Lancet oncology. Volume 20:Issue 12(2019)
- Journal:
- Lancet oncology
- Issue:
- Volume 20:Issue 12(2019)
- Issue Display:
- Volume 20, Issue 12 (2019)
- Year:
- 2019
- Volume:
- 20
- Issue:
- 12
- Issue Sort Value:
- 2019-0020-0012-0000
- Page Start:
- e699
- Page End:
- e714
- Publication Date:
- 2019-12
- Subjects:
- Oncology -- Periodicals
Neoplasms -- Periodicals
Cancérologie -- Périodiques
Oncologie
Oncology
Periodicals
Electronic journals
616.994005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/14702045 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S1470-2045(19)30673-4 ↗
- Languages:
- English
- ISSNs:
- 1470-2045
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.090000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18700.xml